STX vs. ELX, TAO, APC, DGI, IDEA, ANCR, VLG, EAH, DNL, and PXS
Should you be buying Shield Therapeutics stock or one of its competitors? The main competitors of Shield Therapeutics include El Oro (ELX), TAO Alpha (TAO), Apc Technology Group (APC), DG Innovate (DGI), Ideagen (IDEA), Animalcare Group (ANCR), Venture Life Group (VLG), ECO Animal Health Group (EAH), Diurnal Group (DNL), and Provexis (PXS).
Shield Therapeutics vs. Its Competitors
El Oro (LON:ELX) and Shield Therapeutics (LON:STX) are both small-cap computer hardware companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.
In the previous week, El Oro's average media sentiment score of 0.00 equaled Shield Therapeutics'average media sentiment score.
El Oro has higher earnings, but lower revenue than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than El Oro, indicating that it is currently the more affordable of the two stocks.
11.9% of Shield Therapeutics shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
El Oro has a net margin of 0.00% compared to Shield Therapeutics' net margin of -173.43%. El Oro's return on equity of 0.00% beat Shield Therapeutics' return on equity.
Summary
El Oro and Shield Therapeutics tied by winning 4 of the 8 factors compared between the two stocks.
Get Shield Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Shield Therapeutics Competitors List
Related Companies and Tools
This page (LON:STX) was last updated on 8/9/2025 by MarketBeat.com Staff
Free STX Stock Alerts